medigraphic.com
ISSN 0016-3813 (Print)

2009, Number 5

<< Back Next >>

Gac Med Mex 2009; 145 (5)

Comportamiento de la mortalidad por cardiopatía isquémica en México en el periodo 2000-2007

Sánchez-Barriga JJ

Language: Spanish
References: 41
Page: 375-382
PDF size: 77.52 Kb.


ABSTRACT

Objective: To determine the behaviour of mortality due to ischemic cardiopathy in Mexico during the years 2000 through 2007.
Methods: The codes of the International Classification of Diseases 10 that correspond to the ischemic cardiopathy were identified. The rates of mortality nationwide, by federative entity, and by socioeconomic region as well as by degree of education, type of job, and public health services entitlement, were determined. Likewise, the strength of association by means of the regression of Poisson among federative entities, socioeconomic regions where individuals resided in, and mortality by ischemic cardiopathy were also determinated.
Results: Of the studied population (397 934), the majority were retirees and pensioners 230 976 (58 %), had incomplete elementary education 167 945 (42.2 %), and were not entitled to a public health institution 152 787 (38.4 %). The federative entities and the socioeconomic region with the highest strength of association between mortality and ischemic cardiopathy were Chihuahua 2000 (RR = 2.6, CI 95 % = 2.4 - 2.8), 2007 (RR = 1.9, CI 95 % = 1.8 - 2) and Region 7, 2000 (RR 2.6, CI 95 % = 2.5 - 2.7), 2007 (RR 2.3, CI 95 % = 95 % 2.2 - 2.4), respectively.
Conclusions: The mortality was higher among males. The majority were retirees and pensioners, had incomplete elementary school, and were not entitled to any public health institution. The entity and region that presented the highest strength of association between mortality and isquemic cardiopathy were Chihuahua and region 7.


REFERENCES

  1. Organización Mundial de la Salud. Informe sobre la salud en el mundo 2004. Cambiemos el rumbo de la historia. Ginebra, Suiza: Organización Mundial de la Salud; 2004.

  2. Organización Panamericana de la Salud. Salud en las Américas 2007: Volumen I, Regional. Washington, DC: OPS; 2007.

  3. National Center for Health Statistics. Health, United States, 2008 with Chartbook. Hyattsville, MD: 2009. Disponible en: http://www.cdc.gov/nchs/data/hus/hus08.pdf

  4. Murray CJ, López AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997;349:1498-1504.

  5. Bramkamp M, Radovanovic D, Erne P, Szucs TD. Determinants of costs and the length of stay in acute coronary syndromes: a real life analysis of more than 10 000 patients. Cardiovasc Drugs Ther 2007;21:389-398.

  6. Konin C, Ekra A, Adoh A, Kohou L, Avodagbe A, Niamkey T, et al. Assessment of the cost of the curative treatment of myocardial infarction in the Abidjan Cardiology Institute. Bull Soc Pathol Exot 2007;100:201-204.

  7. Rahimi AR, Spertus JA, Reid KJ, Bernheim SM, Krumholz HM. Financial barriers to health care and outcomes after acute myocardial infarction. JAMA 2007;297:1063-1072.

  8. Secretaría de Salud, Sistema Nacional de Información en Salud. Mortalidad. Disponible en http://www.salud.gob.mx/apps/htdocs/estadisticas/mortalidad/

  9. Fernández P, Martínez D, Partida V. La situación demográfica de México. En: Veinticinco años de transición epidemiológica en México. México: Consejo Nacional de Población; 1999. pp. 15-27.

  10. Stevens G, Dias RH, Thomas KJ, Rivera JA, Carvalho N, Barquera S, et al. Characterizing the epidemiological transition in Mexico: national and subnational burden of diseases, injuries, and risk factors. PLoS Med 2008;5:e125.

  11. Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation 2001;104:2746-2753.

  12. Consejo Nacional de Población. La población de México en el nuevo siglo. México: Conapo; 2001. Disponible en http://www.conapo.gob.mx/publicaciones/sdm/Lapoblacion/02.pdf

  13. Consejo Nacional de Población. Indicadores demográficos básicos 1990-2030. Disponible en http://www.conapo.gob.mx

  14. Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases: Part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. Circulation 2001;104:2855-2864.

  15. Hadaegh F, Harati H, Ghanbarian A, Azizi F. Association of total cholesterol versus other serum lipid parameters with the short-term prediction of cardiovascular outcomes: Tehran Lipid and Glucose Study. Eur J Cardiovasc Prev Rehabil 2006;13:571-577.

  16. Christianson TJ, Bryant SC, Weymiller AJ, Smith SA, Montori VM. A penand- paper coronary risk estimator for office use with patients with type 2 diabetes. Mayo Clin Proc 2006;81:632-636.

  17. Miura K, Dyer AR, Greenland P, Daviglus ML, Hill M, Liu K, et al. Pulse pressure compared with other blood pressure indexes in the prediction of 25- year cardiovascular and all-cause mortality rates: The Chicago Heart Association Detection Project in Industry Study. Hypertension 2001;38:232-237.

  18. Cullen P, Assmann G. High risk strategies for atherosclerosis. Clin Chem Acta 1999;286:31-45.

  19. Gregg EW, Cheng YJ, Cadwell BL, Imperatore G, Williams DE, Flegal KM, et al. Secular trends in cardiovascular disease risk factors according to body mass index in US adults. JAMA 2005;293:1868-1874.

  20. Flegal KM, Graubard BI, Williamson DF, Gail MH. Cause-specific excess deaths associated with underweight, overweight, and obesity. JAMA 2007;298:2028-2037.

  21. US Department of Health and Human Services. The health consequences of smoking: A report of the Surgeon General. Atlanta, GA: US Department of Health and Human Services, CDC, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2004. Disponible en http://www.cdc.gov/tobacco/data_statistics/sgr/sgr_2004/index.htm

  22. Reddy KS, Yusuf S. Emerging epidemic of cardiovascular disease in developing countries. Circulation 1998;97:596-601.

  23. Organización Mundial de la Salud. Clasificación Estadística Internacional de Enfermedades y Problemas Relacionados con la Salud. Décima revisión. Ginebra, Suiza: Organización Mundial de la Salud; 1995.

  24. Organización Panamericana de la Salud. Sobre la estimación de tasas de mortalidad para países de la región de las Américas. Boletín Epidemiológico, 2003;24(4). Disponible en http://www.paho.org/Spanish/DD/AIS/be_v24n4-cover.htm

  25. Inskip H, Beral V, Fraser P, Haskey J. Methods for age-adjustment of rates. Stat Med 1983;2:455-466.

  26. Anexo del Sexto Informe de Gobierno 2006. Proyecciones de población y principales características por entidad federativa. En: Desarrollo Humano y Social. México: Secretaría de Gobernación; 2006. pp. 14-22.

  27. Instituto Nacional de Estadística y Geografía. Regiones socioeconómicas de México. Disponible en http://www.inegi.org.mx/est/contenidos/espanol/sistemas/regsoc/default.asp?s=est&c=11723.

  28. Cameron AC, Trivedi PK. Regression analysis of count data. Cambridge: Cambridge University Press; 1998.

  29. Rogot E, Sorlie PD, Johnson NJ, Schmitt C. Mortality study of 1.3 million persons by demographic, social, and economic factors: 1979-1985 follow-up. NIH Publication No. 92-3297:1-5.

  30. Ribet C, Melchior M, Lang T, Zins M, Goldberg M, Leclerc A. Characterization and measurement of social position in epidemiologic studies. Rev Epidemiol Sante Publique 2007;55:285-295.

  31. Siegel D, Kuller L, Lazarus NB, Black D, Feigal D, Hughes G, et al. Predictors of cardiovascular events and mortality in the systolic hypertension in the elderly program pilot project. Am J Epidemiol 1987;126:385-399.

  32. Instituto Nacional de Estadística y Geografía. Censos de población y vivienda, 1960, 1970, 1990 y 2000. Disponible en http://www.inegi.org.mx/est/contenidos/espanol/rutinas/ept.asp?t=medu09&s=est&c=5719.

  33. Instituto Nacional de Estadística y Geografía. Escolaridad nacional de 15 y más años de 1960 a 2005. Disponible en http://www.inegi.org.mx/est/contenidos/espanol/rutinas/ept.asp?t=medu09&s=est&c=5719.

  34. Hernández B, Peterson K, Sobol A, Rivera J, Sepúlveda J, Lezana MA. Sobrepeso en mujeres de 12 a 49 años y niños menores de cinco años en México. Salud Publica Mex 1996;38:178-188.

  35. Velázquez-Monroy O, Rosas-Peralta M, Lara-Esqueda A, Pastelín-Hernández G, Sánchez-Castillo C, Attié F, et al. Prevalencia e interrelación de enfermedades crónicas no transmisibles y factores de riesgo cardiovascular en México. Resultados finales de la Encuesta Nacional de Salud (ENSA) 2000. Arch Cardiol Mex 2003;73:62-77.

  36. Lara A, Rosas M, Pastelín G, Aguilar C, Attié F, Velázquez-Monroy O. Hipercolesterolemia e hipertensión arterial en México. Consolidación urbana actual con obesidad, diabetes y tabaquismo. Arch Cardiol Mex 2004;74:231-245.

  37. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress, hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 2000;355:773-778.

  38. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004;364:937-952.

  39. Frenk J, Bobadilla JL, Sepúlveda J, Cervantes ML. Health transition in middle-income countries: new challenges for health care. Health Policy Plan 1989;4:29-39.

  40. Consejo Nacional de Población. Índices de Marginación, 2005. México: Conapo; 2006. Disponible en http://www.conapo.gob.mx/publicaciones/margina2005/01_b.pdf

  41. Kaplan GA, Keil JE. Socioeconomic factors and cardiovascular disease: a review of the literature. Circulation 1993;88:1973-1998.




2020     |     www.medigraphic.com